Your browser doesn't support javascript.
loading
Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial.
Watson-Jones, Deborah; Changalucha, John; Whitworth, Hilary; Pinto, Ligia; Mutani, Paul; Indangasi, Jackton; Kemp, Troy; Hashim, Ramadhan; Kamala, Beatrice; Wiggins, Rebecca; Songoro, Twaib; Connor, Nicholas; Mbwanji, Gladys; Pavon, Miquel A; Lowe, Brett; Mmbando, Devis; Kapiga, Saidi; Mayaud, Philippe; de SanJosé, Silvia; Dillner, Joakim; Hayes, Richard J; Lacey, Charles J; Baisley, Kathy.
Afiliación
  • Watson-Jones D; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: deborah.watson-jones@lshtm.ac.uk.
  • Changalucha J; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.
  • Whitworth H; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
  • Pinto L; HPV Serology Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD, USA.
  • Mutani P; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.
  • Indangasi J; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
  • Kemp T; HPV Serology Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD, USA.
  • Hashim R; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.
  • Kamala B; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.
  • Wiggins R; York Biomedical Research Institute & Hull York Medical School, University of York, York, UK.
  • Songoro T; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.
  • Connor N; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
  • Mbwanji G; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.
  • Pavon MA; Infection and Cancer Laboratory, Cancer Epidemiology Research Programme, ICO-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain.
  • Lowe B; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
  • Mmbando D; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.
  • Kapiga S; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
  • Mayaud P; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
  • de SanJosé S; Unit of Infections and Cancer Cancer Epidemiology Research Programme, Institut Català d' Oncologia, Barcelona, Spain; National Cancer Institute, Rockville, USA.
  • Dillner J; Karolinska Institute, Stockholm, Sweden.
  • Hayes RJ; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
  • Lacey CJ; York Biomedical Research Institute & Hull York Medical School, University of York, York, UK.
  • Baisley K; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
Lancet Glob Health ; 10(10): e1473-e1484, 2022 10.
Article en En | MEDLINE | ID: mdl-36113531
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Papillomavirus / Vacunas contra Papillomavirus Tipo de estudio: Clinical_trials / Guideline Límite: Female / Humans País/Región como asunto: Africa Idioma: En Revista: Lancet Glob Health Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Papillomavirus / Vacunas contra Papillomavirus Tipo de estudio: Clinical_trials / Guideline Límite: Female / Humans País/Región como asunto: Africa Idioma: En Revista: Lancet Glob Health Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido